Voloridge Investment Management’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-99,642
| Closed | -$4.78M | – | 1616 |
|
|
2020
Q1 | $4.78M | Buy |
99,642
+15,642
| +19% | +$751K | 0.14% | 167 |
|
|
2019
Q4 | $3.94M | Buy |
+84,000
| New | +$3.94M | 0.08% | 332 |
|
|
2019
Q3 | – | Sell |
-14,207
| Closed | -$427K | – | 1282 |
|
|
2019
Q2 | $427K | Sell |
14,207
-13,670
| -49% | -$411K | 0.01% | 592 |
|
|
2019
Q1 | $624K | Buy |
+27,877
| New | +$624K | 0.02% | 608 |
|